CN Stock MarketDetailed Quotes

688506 Sichuan Biokin Pharmaceutical

Watchlist

189.34
+3.18+1.71%

Market Closed May 14 15:00 CST

75.93BMarket Cap17.29P/E (TTM)

Sichuan Biokin Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

Assets

Current assets

Money funds

689.82%5.83B

-59.79%403.96M

296.67%414.11M

582.91%632.76M

--737.61M

551.49%1B

--104.39M

-26.89%92.66M

241.11%154.22M

--126.74M

Transactional financial assets

----

--30.02M

Notes receivable and accounts receivable

-43.00%119.89M

-52.24%118.13M

-28.30%125.56M

43.01%213.81M

--210.34M

93.06%247.34M

--175.12M

-2.35%149.51M

-35.30%128.12M

--153.1M

-Notes receivable

24.31%24.6M

4.76%19.74M

-3.64%12.78M

6.43%14.14M

--19.79M

-17.86%18.84M

--13.27M

-49.86%13.29M

-34.01%22.94M

--26.5M

-Accounts receivable

-49.99%95.29M

-56.94%98.39M

-30.32%112.78M

46.58%199.67M

--190.55M

117.25%228.5M

--161.85M

7.60%136.22M

-35.57%105.18M

--126.6M

Other receivables (including interest and dividends)

204.17%10.14M

-23.97%3.9M

-5.47%3.67M

21.61%3.95M

--3.33M

74.06%5.14M

--3.88M

16.66%3.25M

-20.02%2.95M

--2.78M

-Other receivable

----

-23.97%3.9M

----

21.61%3.95M

----

74.06%5.14M

--3.88M

16.66%3.25M

-20.02%2.95M

--2.78M

Advance payment

131.16%62.94M

91.66%57.2M

101.15%50.29M

48.55%32.52M

--27.23M

30.23%29.84M

--25M

38.72%21.89M

74.30%22.92M

--15.78M

Inventories

25.73%152.89M

39.06%140.91M

52.06%136.29M

44.92%132.96M

--121.6M

23.08%101.33M

--89.63M

16.73%91.75M

25.17%82.33M

--78.6M

Receivable financing

-28.25%6.32M

-4.22%19.71M

-15.70%8.99M

168.39%16.11M

--8.81M

201.31%20.58M

--10.66M

-20.07%6M

-76.01%6.83M

--7.51M

Other current assets

102.83%42.22M

84.20%32M

49.25%17.39M

168.23%26.67M

--20.82M

-34.31%17.37M

--11.65M

-47.74%9.94M

39.73%26.45M

--19.03M

Total current assets

450.59%6.22B

-45.61%775.82M

79.92%756.3M

182.35%1.06B

--1.13B

236.55%1.43B

--420.34M

-13.51%374.99M

-25.75%423.81M

--433.57M

Non Current assets

Investment real estate

-14.01%1.53M

-13.54%1.59M

-13.10%1.65M

-12.68%1.72M

--1.78M

-11.93%1.84M

--1.9M

-11.25%1.97M

-10.65%2.09M

--2.22M

Fixed assets

----

31.25%447.63M

----

-7.84%325.89M

----

-8.52%341.04M

--347.93M

22.32%353.61M

22.56%372.82M

--289.08M

Constru in process

----

21.06%81.37M

----

87.40%105.34M

----

269.80%67.21M

--61.92M

-44.37%56.21M

-76.31%18.18M

--101.04M

Intangible assets

-5.20%27.63M

-5.19%28M

-5.20%28.37M

-5.22%28.75M

--29.14M

-5.23%29.53M

--29.93M

-5.20%30.33M

-5.23%31.16M

--32M

Development expenditure

----

--6.83M

----

Long deferred expense

-20.51%2.12M

1.38%1.82M

52.78%2.6M

44.88%2.24M

--2.67M

54.15%1.79M

--1.7M

1,884.56%1.54M

73.00%1.16M

--77.77K

Deferred tax assets

-15.11%78.13M

-8.47%76.18M

30.00%106.04M

32.37%97.24M

--92.04M

26.49%83.23M

--81.57M

20.94%73.46M

36.51%65.8M

--60.74M

Usufruct assets

-35.67%6.8M

-51.83%5.79M

-28.71%7.41M

-23.46%8.97M

--10.57M

-14.15%12.01M

--10.4M

19.23%11.73M

104.33%13.99M

--9.83M

Other non current assets

-85.10%5.92M

-75.69%6.91M

6.10%27.84M

79.08%35.61M

--39.71M

26.67%28.43M

--26.24M

201.70%19.89M

265.96%22.45M

--6.59M

Total non current assets

9.14%651.12M

14.90%649.28M

16.58%654.69M

10.39%605.77M

--596.62M

7.10%565.09M

--561.59M

9.40%548.74M

10.39%527.64M

--501.58M

Total assets

298.02%6.87B

-28.44%1.43B

43.69%1.41B

80.20%1.66B

--1.73B

109.30%1.99B

--981.93M

-1.22%923.73M

-9.28%951.46M

--935.15M

Liabilities

Current liabilities

Short term loan

177.42%375.45M

77.34%275.12M

14.77%168.02M

-9.28%178.04M

--135.34M

-3.78%155.13M

--146.39M

39.00%196.25M

7.34%161.23M

--141.19M

Notes payable and accounts payable

45.02%333.05M

71.99%339.07M

96.40%296.96M

156.02%291.6M

--229.65M

171.72%197.14M

--151.2M

121.25%113.9M

6.77%72.55M

--51.48M

-Notes payable

-26.44%27.92M

159.90%31.17M

498.17%57.17M

267.09%53.05M

--37.95M

--11.99M

--9.56M

--14.45M

----

-Accounts payable

59.17%305.13M

66.30%307.9M

69.29%239.79M

139.88%238.55M

--191.7M

155.19%185.15M

--141.65M

93.18%99.44M

6.77%72.55M

--51.48M

Contract liabilities

4,569.19%358.37M

-50.21%8.67M

58.67%7.98M

-9.29%4.75M

--7.68M

61.52%17.42M

--5.03M

-52.60%5.23M

-40.41%10.78M

--11.04M

Salaries payable

21.00%26.88M

10.74%44.29M

11.86%34.4M

20.40%28.89M

--22.22M

44.99%40M

--30.76M

27.34%24M

11.58%27.58M

--18.85M

Taxs payable

657.28%76.24M

-47.94%17.87M

-84.19%3.15M

-16.25%13.44M

--10.07M

231.60%34.34M

--19.96M

43.32%16.04M

-53.93%10.35M

--11.19M

Other payable (including interest and dividends)

-16.76%117.65M

-23.59%136.64M

-15.14%121.65M

5.25%143.91M

--141.34M

26.60%178.82M

--143.36M

-31.20%136.73M

-37.11%141.24M

--198.74M

-Dividend payable

----

--16.36M

-Other payable

----

-23.59%136.64M

----

5.25%143.91M

----

26.60%178.82M

--143.36M

-25.03%136.73M

-37.11%141.24M

--182.38M

Non current liabilities due within one year

215.98%303.44M

122.07%220.5M

75.62%158.8M

38.48%90.18M

--96.03M

309.43%99.29M

--90.42M

1,979.92%65.12M

1,463.71%24.25M

--3.13M

Other current liabilities

61.22%24.76M

-22.61%11.66M

0.78%12.69M

-7.80%10.14M

--15.36M

-35.38%15.07M

--12.59M

-56.61%11M

-4.44%23.32M

--25.35M

Total current liabilities

145.69%1.62B

42.95%1.05B

34.01%803.65M

33.91%760.94M

--657.68M

56.41%737.2M

--599.71M

23.28%568.26M

-11.74%471.32M

--460.96M

Current liabilities

Long term account payable

----

-83.83%7.64M

----

-66.36%26.21M

----

11.23%47.22M

--53.29M

--77.92M

--42.46M

----

Estimate liabilities

-19.62%11.33M

-20.35%11.19M

-9.55%11.94M

5.00%14.18M

--14.1M

-11.12%14.05M

--13.21M

-34.34%13.5M

-21.50%15.81M

--20.56M

Deferred tax liabilities

----

--69.69K

--68.96K

----

--84.92K

----

--5.73K

Long term deferred income

16.49%15.23M

17.59%15.63M

11.42%14.11M

-0.80%12.75M

--13.07M

-57.19%13.29M

--12.66M

-66.35%12.85M

-16.64%31.04M

--38.2M

Lease liabilities

-14.24%3.41M

-82.24%1.02M

-58.47%2.12M

-60.12%2.51M

--3.98M

-36.20%5.72M

--5.1M

-5.37%6.28M

71.81%8.97M

--6.64M

Total non current liabilities

-67.24%99.88M

-31.51%219.39M

-34.22%190.9M

87.25%300.65M

--304.84M

116.03%320.33M

--290.23M

145.50%160.56M

136.53%148.28M

--65.4M

Total liabilities

78.25%1.72B

20.40%1.27B

11.75%994.56M

45.66%1.06B

--962.52M

70.68%1.06B

--889.95M

38.46%728.82M

3.84%619.61M

--526.36M

Shareholders equity

Paid-in capital

0.00%401M

11.11%401M

--401M

11.11%401M

--360.9M

0.00%360.9M

--360.9M

Capital reserve funds

0.02%858.69M

5,935.84%858.6M

5,946.08%858.6M

--858.55M

5,960.23%858.55M

--14.22M

0.93%14.2M

0.72%14.17M

--14.07M

Surplus reserve funds

0.00%13.54M

--13.54M

0.00%13.54M

--13.54M

0.00%13.54M

--13.54M

Retained profit

863.21%3.88B

-228.23%-1.12B

-183.50%-857.09M

-239.89%-670.3M

---508.73M

-474.63%-341.98M

---302.32M

-1,260.50%-197.21M

-198.41%-59.51M

--16.99M

Other composite income

37.78%-321.01K

-59.69%1.13M

-93.19%384.68K

-96.14%134.72K

---515.95K

1.24%2.79M

--5.64M

6.20%3.49M

-10.88%2.76M

--3.29M

Shareholders equity without minority interests

574.96%5.16B

-83.74%151.87M

352.71%416.43M

209.35%602.97M

--763.84M

181.42%933.89M

--91.99M

-52.32%194.91M

-26.59%331.85M

--408.79M

Total shareholder equity

574.96%5.16B

-83.74%151.87M

352.71%416.43M

209.35%602.97M

--763.84M

181.42%933.89M

--91.99M

-52.32%194.91M

-26.59%331.85M

--408.79M

Total liabilityies and equity

298.02%6.87B

-28.44%1.43B

43.69%1.41B

80.20%1.66B

--1.73B

109.30%1.99B

--981.93M

-1.22%923.73M

-9.28%951.46M

--935.15M

Currency Unit

CNY

Accounting Standards

CAS (2007)

	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021
Assets
Current assets
Money funds	689.82%5.83B	-59.79%403.96M	296.67%414.11M	582.91%632.76M	--737.61M	551.49%1B	--104.39M	-26.89%92.66M	241.11%154.22M	--126.74M
Transactional financial assets	----	----	----	----	----	----	----	----	----	--30.02M
Notes receivable and accounts receivable	-43.00%119.89M	-52.24%118.13M	-28.30%125.56M	43.01%213.81M	--210.34M	93.06%247.34M	--175.12M	-2.35%149.51M	-35.30%128.12M	--153.1M
-Notes receivable	24.31%24.6M	4.76%19.74M	-3.64%12.78M	6.43%14.14M	--19.79M	-17.86%18.84M	--13.27M	-49.86%13.29M	-34.01%22.94M	--26.5M
-Accounts receivable	-49.99%95.29M	-56.94%98.39M	-30.32%112.78M	46.58%199.67M	--190.55M	117.25%228.5M	--161.85M	7.60%136.22M	-35.57%105.18M	--126.6M
Other receivables (including interest and dividends)	204.17%10.14M	-23.97%3.9M	-5.47%3.67M	21.61%3.95M	--3.33M	74.06%5.14M	--3.88M	16.66%3.25M	-20.02%2.95M	--2.78M
-Other receivable	----	-23.97%3.9M	----	21.61%3.95M	----	74.06%5.14M	--3.88M	16.66%3.25M	-20.02%2.95M	--2.78M
Advance payment	131.16%62.94M	91.66%57.2M	101.15%50.29M	48.55%32.52M	--27.23M	30.23%29.84M	--25M	38.72%21.89M	74.30%22.92M	--15.78M
Inventories	25.73%152.89M	39.06%140.91M	52.06%136.29M	44.92%132.96M	--121.6M	23.08%101.33M	--89.63M	16.73%91.75M	25.17%82.33M	--78.6M
Receivable financing	-28.25%6.32M	-4.22%19.71M	-15.70%8.99M	168.39%16.11M	--8.81M	201.31%20.58M	--10.66M	-20.07%6M	-76.01%6.83M	--7.51M
Other current assets	102.83%42.22M	84.20%32M	49.25%17.39M	168.23%26.67M	--20.82M	-34.31%17.37M	--11.65M	-47.74%9.94M	39.73%26.45M	--19.03M
Total current assets	450.59%6.22B	-45.61%775.82M	79.92%756.3M	182.35%1.06B	--1.13B	236.55%1.43B	--420.34M	-13.51%374.99M	-25.75%423.81M	--433.57M
Non Current assets
Investment real estate	-14.01%1.53M	-13.54%1.59M	-13.10%1.65M	-12.68%1.72M	--1.78M	-11.93%1.84M	--1.9M	-11.25%1.97M	-10.65%2.09M	--2.22M
Fixed assets	----	31.25%447.63M	----	-7.84%325.89M	----	-8.52%341.04M	--347.93M	22.32%353.61M	22.56%372.82M	--289.08M
Constru in process	----	21.06%81.37M	----	87.40%105.34M	----	269.80%67.21M	--61.92M	-44.37%56.21M	-76.31%18.18M	--101.04M
Intangible assets	-5.20%27.63M	-5.19%28M	-5.20%28.37M	-5.22%28.75M	--29.14M	-5.23%29.53M	--29.93M	-5.20%30.33M	-5.23%31.16M	--32M
Development expenditure	----	----	--6.83M	----	----	----	----	----	----	----
Long deferred expense	-20.51%2.12M	1.38%1.82M	52.78%2.6M	44.88%2.24M	--2.67M	54.15%1.79M	--1.7M	1,884.56%1.54M	73.00%1.16M	--77.77K
Deferred tax assets	-15.11%78.13M	-8.47%76.18M	30.00%106.04M	32.37%97.24M	--92.04M	26.49%83.23M	--81.57M	20.94%73.46M	36.51%65.8M	--60.74M
Usufruct assets	-35.67%6.8M	-51.83%5.79M	-28.71%7.41M	-23.46%8.97M	--10.57M	-14.15%12.01M	--10.4M	19.23%11.73M	104.33%13.99M	--9.83M
Other non current assets	-85.10%5.92M	-75.69%6.91M	6.10%27.84M	79.08%35.61M	--39.71M	26.67%28.43M	--26.24M	201.70%19.89M	265.96%22.45M	--6.59M
Total non current assets	9.14%651.12M	14.90%649.28M	16.58%654.69M	10.39%605.77M	--596.62M	7.10%565.09M	--561.59M	9.40%548.74M	10.39%527.64M	--501.58M
Total assets	298.02%6.87B	-28.44%1.43B	43.69%1.41B	80.20%1.66B	--1.73B	109.30%1.99B	--981.93M	-1.22%923.73M	-9.28%951.46M	--935.15M
Liabilities
Current liabilities
Short term loan	177.42%375.45M	77.34%275.12M	14.77%168.02M	-9.28%178.04M	--135.34M	-3.78%155.13M	--146.39M	39.00%196.25M	7.34%161.23M	--141.19M
Notes payable and accounts payable	45.02%333.05M	71.99%339.07M	96.40%296.96M	156.02%291.6M	--229.65M	171.72%197.14M	--151.2M	121.25%113.9M	6.77%72.55M	--51.48M
-Notes payable	-26.44%27.92M	159.90%31.17M	498.17%57.17M	267.09%53.05M	--37.95M	--11.99M	--9.56M	--14.45M	----	----
-Accounts payable	59.17%305.13M	66.30%307.9M	69.29%239.79M	139.88%238.55M	--191.7M	155.19%185.15M	--141.65M	93.18%99.44M	6.77%72.55M	--51.48M
Contract liabilities	4,569.19%358.37M	-50.21%8.67M	58.67%7.98M	-9.29%4.75M	--7.68M	61.52%17.42M	--5.03M	-52.60%5.23M	-40.41%10.78M	--11.04M
Salaries payable	21.00%26.88M	10.74%44.29M	11.86%34.4M	20.40%28.89M	--22.22M	44.99%40M	--30.76M	27.34%24M	11.58%27.58M	--18.85M
Taxs payable	657.28%76.24M	-47.94%17.87M	-84.19%3.15M	-16.25%13.44M	--10.07M	231.60%34.34M	--19.96M	43.32%16.04M	-53.93%10.35M	--11.19M
Other payable (including interest and dividends)	-16.76%117.65M	-23.59%136.64M	-15.14%121.65M	5.25%143.91M	--141.34M	26.60%178.82M	--143.36M	-31.20%136.73M	-37.11%141.24M	--198.74M
-Dividend payable	----	----	----	----	----	----	----	----	----	--16.36M
-Other payable	----	-23.59%136.64M	----	5.25%143.91M	----	26.60%178.82M	--143.36M	-25.03%136.73M	-37.11%141.24M	--182.38M
Non current liabilities due within one year	215.98%303.44M	122.07%220.5M	75.62%158.8M	38.48%90.18M	--96.03M	309.43%99.29M	--90.42M	1,979.92%65.12M	1,463.71%24.25M	--3.13M
Other current liabilities	61.22%24.76M	-22.61%11.66M	0.78%12.69M	-7.80%10.14M	--15.36M	-35.38%15.07M	--12.59M	-56.61%11M	-4.44%23.32M	--25.35M
Total current liabilities	145.69%1.62B	42.95%1.05B	34.01%803.65M	33.91%760.94M	--657.68M	56.41%737.2M	--599.71M	23.28%568.26M	-11.74%471.32M	--460.96M
Current liabilities
Long term account payable	----	-83.83%7.64M	----	-66.36%26.21M	----	11.23%47.22M	--53.29M	--77.92M	--42.46M	----
Estimate liabilities	-19.62%11.33M	-20.35%11.19M	-9.55%11.94M	5.00%14.18M	--14.1M	-11.12%14.05M	--13.21M	-34.34%13.5M	-21.50%15.81M	--20.56M
Deferred tax liabilities	----	----	--69.69K	--68.96K	----	--84.92K	----	----	----	--5.73K
Long term deferred income	16.49%15.23M	17.59%15.63M	11.42%14.11M	-0.80%12.75M	--13.07M	-57.19%13.29M	--12.66M	-66.35%12.85M	-16.64%31.04M	--38.2M
Lease liabilities	-14.24%3.41M	-82.24%1.02M	-58.47%2.12M	-60.12%2.51M	--3.98M	-36.20%5.72M	--5.1M	-5.37%6.28M	71.81%8.97M	--6.64M
Total non current liabilities	-67.24%99.88M	-31.51%219.39M	-34.22%190.9M	87.25%300.65M	--304.84M	116.03%320.33M	--290.23M	145.50%160.56M	136.53%148.28M	--65.4M
Total liabilities	78.25%1.72B	20.40%1.27B	11.75%994.56M	45.66%1.06B	--962.52M	70.68%1.06B	--889.95M	38.46%728.82M	3.84%619.61M	--526.36M
Shareholders equity
Paid-in capital	0.00%401M	0.00%401M	11.11%401M	11.11%401M	--401M	11.11%401M	--360.9M	0.00%360.9M	0.00%360.9M	--360.9M
Capital reserve funds	0.02%858.69M	0.02%858.69M	5,935.84%858.6M	5,946.08%858.6M	--858.55M	5,960.23%858.55M	--14.22M	0.93%14.2M	0.72%14.17M	--14.07M
Surplus reserve funds	0.00%13.54M	0.00%13.54M	0.00%13.54M	0.00%13.54M	--13.54M	0.00%13.54M	--13.54M	0.00%13.54M	0.00%13.54M	--13.54M
Retained profit	863.21%3.88B	-228.23%-1.12B	-183.50%-857.09M	-239.89%-670.3M	---508.73M	-474.63%-341.98M	---302.32M	-1,260.50%-197.21M	-198.41%-59.51M	--16.99M
Other composite income	37.78%-321.01K	-59.69%1.13M	-93.19%384.68K	-96.14%134.72K	---515.95K	1.24%2.79M	--5.64M	6.20%3.49M	-10.88%2.76M	--3.29M
Shareholders equity without minority interests	574.96%5.16B	-83.74%151.87M	352.71%416.43M	209.35%602.97M	--763.84M	181.42%933.89M	--91.99M	-52.32%194.91M	-26.59%331.85M	--408.79M
Total shareholder equity	574.96%5.16B	-83.74%151.87M	352.71%416.43M	209.35%602.97M	--763.84M	181.42%933.89M	--91.99M	-52.32%194.91M	-26.59%331.85M	--408.79M
Total liabilityies and equity	298.02%6.87B	-28.44%1.43B	43.69%1.41B	80.20%1.66B	--1.73B	109.30%1.99B	--981.93M	-1.22%923.73M	-9.28%951.46M	--935.15M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

688506 Sichuan Biokin Pharmaceutical

Sichuan Biokin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target